Table 1

Basic characteristic of the cohort classified by symptom severity

Oligo/asymptomatic participants*Symptomatic participants†Hospital admitted participants
N (%)17 (11)107 (71)25 (16)
Male (%)11 (64)40 (37)20 (80)
Age (median; p25, p75)42 (33–57)53 (39–59)56 (54–64)
Clinical signs and symptoms
Fever7 (44)94 (83)23 (92)
Headache/musculoskeletal pain3 (19)58 (51)11 (44)
Ageusia/anosmia7 (43)59 (52)3 (12)
Asthenia1 (6)59 (52)8 (32)
Cough0 (0)43 (38)23 (92)
Dyspnoea0 (0)17 (15)25 (100)
Pneumonia0 (0)3 (3)25 (100)
Treatment
Antibiotic0 (0)28 (25)25 (100)
Hydroxychloroquine0 (0)12 (10)25 (75)
Heparin0 (0)1 (1)24 (96)
Antiviral0 (0)0 (0)8 (32)
Monoclonal antibody0 (0)0 (0)4 (16)
Steroids0 (0)14 (13)5 (20)
NSAIDs0 (0)7 (6)0 (21)
Paracetamol1 (6)20 (18)1 (4)
  • *Oligosymptomatic patients are those with symptoms enduring for less than 3 days or with only one symptom (anosmia/ageusia or asthenia).

  • †Symptomatic patients are those with one more symptom lasting at least 3 days and without any hospital admission.

  • NSAIDs, Non-steroidal anti-inflammatory drugs.